MedTrace Logo

Inflammatory Markers in Sputum After LPS Inhalation

NCT01081392 · Status: UNKNOWN · Phase: NA · Type: INTERVENTIONAL · Enrollment: 12

Last updated 2010-03-05

No results posted yet for this study

Summary

The purpose of the study is to measure inflammatory biomarkers in sputum and peripheral blood in healthy volunteers after inhalation of single doses of LPS (20 mcg) administered as particles of different sizes.

Conditions

Interventions

BIOLOGICAL

LPS

LPS 20mcg sd inhaled via nebulizer, 3 periods

Sponsors & Collaborators

  • Centre Hospitalier Universitaire Brugmann

    lead OTHER

Principal Investigators

  • Olivier MICHEL, MD, PhD · CHU Brugmann

Study Design

Allocation
RANDOMIZED
Purpose
BASIC_SCIENCE
Masking
SINGLE
Model
CROSSOVER

Eligibility

Min Age
18 Years
Max Age
55 Years
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2010-01-31
Primary Completion
2010-04-30
Completion
2010-05-31

Countries

  • Belgium

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT01081392 on ClinicalTrials.gov